COMPOSITE PREPARATION FOR TREATING TYPE 2 DIABETES AND DIABETIC DYSLIPIDEMIA

摘要

The present invention relates to a composite preparation for efficiently treating type 2 diabetes and dyslipidemia in a patient with diabetes. More specifically, the present invention is to efficiently control blood glucose and reduce risk factors in cardiovascular diseases by providing a composite preparation containing gemigliptin as a peptidase IV inhibitor or a pharmaceutically acceptable salt thereof, in addition to rosuvastatin as an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof.;COPYRIGHT KIPO 2018